These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 33066908)
1. Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature. Anand P; Lau KHV; Chung DY; Virmani D; Cervantes-Arslanian AM; Mian AZ; Takahashi CE J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105212. PubMed ID: 33066908 [TBL] [Abstract][Full Text] [Related]
2. Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient. Princiotta Cariddi L; Tabaee Damavandi P; Carimati F; Banfi P; Clemenzi A; Marelli M; Giorgianni A; Vinacci G; Mauri M; Versino M J Neurol; 2020 Nov; 267(11):3157-3160. PubMed ID: 32583053 [TBL] [Abstract][Full Text] [Related]
3. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19. Kishfy L; Casasola M; Banankhah P; Parvez A; Jan YJ; Shenoy AM; Thomson C; AbdelRazek MA J Neurol Sci; 2020 Jul; 414():116943. PubMed ID: 32474362 [TBL] [Abstract][Full Text] [Related]
4. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126 [TBL] [Abstract][Full Text] [Related]
5. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Maes B; Bosteels C; De Leeuw E; Declercq J; Van Damme K; Delporte A; Demeyere B; Vermeersch S; Vuylsteke M; Willaert J; Bollé L; Vanbiervliet Y; Decuypere J; Libeer F; Vandecasteele S; Peene I; Lambrecht B Trials; 2020 Jun; 21(1):468. PubMed ID: 32493441 [TBL] [Abstract][Full Text] [Related]
6. Hypotension, Systemic Inflammatory Response Syndrome, and COVID-19: A Clinical Conundrum. Hanidziar D; Bittner EA Anesth Analg; 2020 Sep; 131(3):e175-e176. PubMed ID: 32541247 [No Abstract] [Full Text] [Related]
7. Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic. Gleeson SE; Formica RN; Marin EP Clin J Am Soc Nephrol; 2020 Jun; 15(6):892-895. PubMed ID: 32345749 [No Abstract] [Full Text] [Related]
8. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. Franceschi AM; Ahmed O; Giliberto L; Castillo M AJNR Am J Neuroradiol; 2020 Jul; 41(7):1173-1176. PubMed ID: 32439646 [TBL] [Abstract][Full Text] [Related]
9. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514 [TBL] [Abstract][Full Text] [Related]
10. Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient. Korkmazer B; Ozogul M; Hikmat E; Kilic H; Aygun F; Arslan S; Kizilkilic O; Kocer N Pediatr Infect Dis J; 2021 Jun; 40(6):e240-e242. PubMed ID: 33742613 [TBL] [Abstract][Full Text] [Related]
12. COVID-19-related Mortality During the First 60 Days After Kidney Transplantation. Pascual J; Melilli E; Jiménez-Martín C; González-Monte E; Zárraga S; Gutiérrez-Dalmau A; López-Jiménez V; Juega J; Muñoz-Cepeda M; Lorenzo I; Facundo C; Ruiz-Fuentes MDC; Mazuecos A; Sánchez-Álvarez E; Crespo M; Eur Urol; 2020 Oct; 78(4):641-643. PubMed ID: 32624283 [No Abstract] [Full Text] [Related]
13. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803 [TBL] [Abstract][Full Text] [Related]
15. [COVID-19- what have we learned and where are we heading?]. Gudnason T Laeknabladid; 2020 Oct; 106(10):449. PubMed ID: 32991305 [No Abstract] [Full Text] [Related]
17. Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes. D'Amore F; Vinacci G; Agosti E; Cariddi LP; Terrana AV; Vizzari FA; Mauri M; Giorgianni A AJNR Am J Neuroradiol; 2020 Oct; 41(10):1800-1803. PubMed ID: 32732268 [TBL] [Abstract][Full Text] [Related]
18. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related]
19. Posterior reversible encephalopathy syndrome (PRES) associated with SARS-CoV-2 infection in a patient under maintenance haemodialysis: a case report. Shimamoto Y; Sasaki H; Kasuno K; Watanabe Y; Sakashita S; Nishikawa S; Nishimori K; Morita S; Nishikawa Y; Kobayashi M; Fukushima S; Enomoto S; Takahashi N; Hamano T; Sakamaki I; Iwasaki H; Iwano M BMC Nephrol; 2023 Sep; 24(1):286. PubMed ID: 37773103 [TBL] [Abstract][Full Text] [Related]
20. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. Zhu F; Cao Y; Xu S; Zhou M J Med Virol; 2020 Jun; 92(6):529-530. PubMed ID: 32160316 [No Abstract] [Full Text] [Related] [Next] [New Search]